SOX4 anticorps (full length)

N° du produit ABIN7879075

Cet anticorps anti-SOX4 Monoclonal Souris (Clone SOX4-2540) (ABIN7879075) détecte spécifiquement SOX4 dans IHC (p). L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour SOX4 anticorps (full length) (ABIN7879075)

Antigène: SOX4 (SRY (Sex Determining Region Y)-Box 4 (SOX4))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp SOX4 est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Classe de qualité: Carrier-free

Clone: SOX4-2540

Détail du produit anti-SOX4 anticorps

Épitope: full length

Fonction: SOX4 Antibody (azide and preservative free)

Purification: Protein G affinity chromatography

Immunogène: Full length recombinant human protein was used as the immunogen for the SOX4 antibody.

Isotype: IgG2b, kappa

Information d'application

Indications d'application: Optimal dilution of the SOX4 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: 4 °C,-20 °C

Stockage commentaire: Store the SOX4 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Détails sur SOX4

Antigène: SOX4 (SRY (Sex Determining Region Y)-Box 4 (SOX4))

Autre désignation: SOX4

Sujet: SOX4 is a member of the SOX (SRY-related HMG-box) family of transcription factors with a critical role in embryonic development and in cell-fate determination during organogenesis of the heart, pancreas, brain, and in B and T lymphocyte differentiation. SOX4 gene expression is upregulated in many cancer types, and increased SOX4 activity contributes to cellular transformation, cell survival, and metastasis. Gene expression profiling has uncovered SOX4 with upregulated activity during TGF-AŽ ²-induced epithelial-mesenchymal transition (EMT) in normal and cancerous breast epithelial cells. SOX4 is indispensable for EMT and cell survival in vitro and for primary tumor growth and metastasis in vivo. SOX4 is identified as a master regulator of EMT by governing the expression of the epigenetic modifier Ezh2.

UniProt: Q06945